An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors
- 1 January 2017
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 19 (1) , 147-161
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (NCI) Cancer Center (P30CA091842)
- NIH/NCI (U01CA114722, U10CA180860)
- Komen (PG 12220321)
This publication has 61 references indexed in Scilit:
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical ModelsCancer Research, 2011
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2010
- Transforming Properties of 8p11-12 Amplified Genes in Human Breast CancerCancer Research, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerCancer Research, 2010
- Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II TrialJournal of the American College of Surgeons, 2009
- Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisOncogene, 2009
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenesOncogene, 2005